E248R is a type II myristoylated transmembrane protein encoded by the ASFV E248R gene. Key features include:
Transmembrane domain: Hydrophobic region (aa ~220–240) critical for membrane integration .
Extracellular domain: 28 aa C-terminal region exposed outside the viral membrane .
Disulfide bonds: Intramolecular linkages formed via cysteine residues, stabilized by the ASFV-encoded redox system .
E248R interacts with host endosomal proteins to facilitate viral core release:
NPC1 interaction: Binds the Niemann-Pick C1 (NPC1) cholesterol transporter’s C-domain via its transmembrane region .
NPC2 compensatory role: Knockout of NPC1 increases NPC2 levels, partially restoring infection, indicating redundancy in cholesterol-dependent processes .
Endosomal retention: In NPC1-KO cells, ASFV cores accumulate in enlarged endosomes, blocking cytoplasmic release .
| Host Protein | Interaction Domain | Functional Impact | Source |
|---|---|---|---|
| NPC1 | C-domain | Critical for membrane fusion and core release | |
| NPC2 | – | Partial compensatory role in NPC1 absence |
Deletion or absence of E248R drastically reduces ASFV infectivity:
100-fold infectivity loss: E248R-deficient virions fail to induce cytopathic effects or gene expression post-entry .
No effect on binding/internalization: Defects occur post-entry, during endosomal escape or core penetration .
E248R shares functional homology with vaccinia virus (VACV) fusion proteins:
VACV L1R: 16.2% identity/30.7% similarity; both mediate membrane fusion via NPC1 interaction .
E199L: ASFV protein with homology to VACV A16/A26/G9 fusion subunits .
Vaccine development: Served as a candidate antigen for ASFV subunit vaccines .
Diagnostic tools: Used in immunoassays to detect anti-ASFV antibodies .
Research models: Incorporated into recombinant viruses (e.g., PRRSV-E248R) to study replication dynamics .
A quantitative PCR method for E248R gene quantification:
| Primer/Probe | Sequence (5′→3′) | Position | Source |
|---|---|---|---|
| E248R-F | GGAGGCTCTACAAGCAAA | 166,996–167,013 | |
| E248R-R | CATCACCGAATACGCCTA | 167,105–167,122 | |
| E248R-P | FAM-AATACGACCAACATTATCAGCAAT-BHQ1 | 167,025–167,050 |
E248R is a structural protein located in the inner membrane of the African swine fever virus particle. The protein contains distinct domains including an external domain, a transmembrane (TM) domain, and an internal domain. The protein is myristoylated and membrane-associated . E248R shares structural similarity with several subunits of the poxvirus multiprotein entry/fusion complex, suggesting potential evolutionary relationships or functional parallels .
The protein contains a C-terminal putative transmembrane region (194SAVFK) and exhibits a characteristic N-terminal sequence (2GGSTSK7) that is consistent with myristoylation sites . This post-translational modification likely contributes to its membrane association properties and may be critical for its function in viral entry and membrane fusion processes.
E248R plays a crucial role in ASFV replication, particularly during the early stages of infection. Studies using recombinant viruses with inducible E248R expression have demonstrated that in the absence of this protein, viral replication is significantly impaired . The protein appears to be involved in viral fusion events necessary for viral entry and potentially in the formation of viral replication sites.
The membrane association properties of E248R suggest it participates in membrane manipulation events that facilitate viral entry and the establishment of replication complexes. Its interaction with host endosomal proteins indicates a role in endosomal escape, allowing viral cores to access the cytoplasm where replication can proceed .
Several complementary experimental approaches have been employed to investigate E248R function:
Recombinant protein expression systems: Expression of E248R as a fusion protein (e.g., with EGFP or HA tags) in cell lines such as HEK 293T cells .
Inducible expression systems: Creation of recombinant viruses with inducible E248R expression to study the effects of E248R absence on viral replication .
Co-immunoprecipitation assays: Used to identify protein-protein interactions between E248R and host cellular factors such as NPC1 .
Domain deletion analysis: Construction of deletion mutants lacking specific protein domains to determine which regions are essential for function and protein-protein interactions .
Reverse pull-down experiments: Confirmation of protein-protein interactions through reciprocal co-immunoprecipitations using antibodies against different epitope tags .
E248R has been demonstrated to interact with several endosomal proteins, most notably Niemann-Pick C1 (NPC1) and lysosomal-associated membrane protein 2 (Lamp2). These interactions have been confirmed through multiple experimental approaches, including co-immunoprecipitation studies .
The interaction between E248R and NPC1 appears to be mediated primarily through the transmembrane domain of E248R. Deletion mutants lacking the TM domain fail to interact with NPC1, while constructs containing this domain maintain the interaction . Specifically, E248R binds to the C domain of NPC1, as demonstrated through co-immunoprecipitation experiments with individual NPC1 domains .
The interaction data can be summarized in the following table:
| Viral Protein | Host Protein | Interacting Domain of Viral Protein | Interacting Domain of Host Protein | Detection Method |
|---|---|---|---|---|
| E248R | NPC1 | Transmembrane domain | C domain | Co-IP/Western Blot |
| E248R | Lamp2 | Not fully characterized | Not fully characterized | Co-IP/Western Blot |
| E199L | NPC1 | Not fully characterized | C domain | Co-IP/Western Blot |
| E199L | Lamp1 | Not fully characterized | Not fully characterized | Co-IP/Western Blot |
| E199L | Lamp2 | Not fully characterized | Not fully characterized | Co-IP/Western Blot |
This interaction with endosomal proteins suggests that E248R plays a critical role in viral escape from endosomes during entry, allowing viral cores to access the cytoplasm for replication .
The interaction between E248R and NPC1 appears to be critical for the endosomal escape of ASFV during viral entry. Studies have shown that in the absence of NPC1, incoming viral cores are retained inside endosomes, preventing them from continuing the infection process .
This mechanism is reminiscent of other viruses that utilize endosomal proteins for entry. For example, Ebola virus also requires NPC1 for viral entry, although through different viral proteins. The conservation of this mechanism across different virus families suggests a convergent evolutionary strategy for endosomal escape.
The functional significance of this interaction makes it a potential target for antiviral development. Disrupting the E248R-NPC1 interaction could potentially inhibit viral entry and thus prevent infection. This approach would target a host-virus interaction rather than a viral component alone, potentially reducing the likelihood of viral resistance through mutation.
Domain deletion studies have provided significant insights into the functional architecture of E248R. Several deletion mutants have been constructed to analyze domain-specific functions:
E248R ΔExt: Lacking the external protein domain
E248R ΔTM: Lacking the transmembrane domain
E248R ΔExt+TM: Lacking both transmembrane and external domains
These deletion studies have revealed that the transmembrane domain is critical for the interaction with NPC1. Mutants lacking the TM domain (E248R ΔTM and E248R ΔExt+TM) fail to interact with NPC1, while the wild-type E248R and E248R ΔExt (which retains the TM domain) maintain this interaction .
This suggests that the TM domain either directly mediates binding to NPC1 or is required for proper protein folding or localization that enables this interaction. These findings have important implications for understanding the molecular mechanisms of viral entry and for designing targeted interventions.
While research on E248R has provided significant insights into its structure and function, several contradictions or knowledge gaps exist in the current literature:
Functional redundancy vs. specificity: Some studies suggest functional overlap between E248R and E199L in interacting with endosomal proteins , while others indicate more specific, non-redundant roles.
Domain specificity inconsistencies: Some pull-down experiments suggest E248R may interact with multiple NPC1 domains (A, C, and I) , while reverse co-immunoprecipitation experiments more specifically identify the C domain as the primary interaction site.
Experimental methodology limitations: Different experimental approaches have sometimes yielded varying results, highlighting the importance of methodological considerations in interpreting protein-protein interaction data.
These contradictions point to areas requiring further research and highlight the complexity of viral-host protein interactions. They also underscore the importance of employing multiple complementary experimental approaches to validate findings in this field.
Based on the current literature, several methodological approaches have proven effective for studying E248R-host protein interactions:
Co-immunoprecipitation with epitope-tagged proteins: This approach has been successfully used to identify interactions between E248R and host endosomal proteins. Both GFP-tagged and HA-tagged versions of E248R have been used effectively .
Reciprocal co-immunoprecipitation: Confirming interactions through pull-downs from both directions (e.g., pulling down E248R to detect NPC1 and pulling down NPC1 to detect E248R) provides stronger evidence for specific interactions .
Domain deletion analysis: Creating deletion mutants lacking specific protein domains helps identify which regions are essential for protein-protein interactions .
Heterologous expression systems: HEK 293T cells have proven useful for protein-protein interaction studies due to their high transfection efficiency .
Functional validation studies: Beyond identifying physical interactions, studies using RNAi knockdown or CRISPR knockout of host factors can validate the functional significance of identified interactions .
A comprehensive approach that combines these methods provides the most robust evidence for protein-protein interactions and their functional significance.
The interaction between E248R and NPC1 represents a promising target for antiviral development based on several considerations:
Essential for viral entry: Disruption of this interaction prevents viral escape from endosomes, effectively blocking infection at an early stage .
Specific binding domain identified: The identification of the C domain of NPC1 as the primary interaction site provides a specific target for intervention .
Structural basis: Further structural studies of this interaction could enable structure-based drug design targeting the specific binding interface.
Potential approaches for targeting this interaction include:
Small molecule inhibitors: Compounds that bind to either the TM domain of E248R or the C domain of NPC1 could disrupt the interaction.
Peptide-based inhibitors: Peptides derived from the interaction interface could competitively inhibit binding.
Antibody-based approaches: Antibodies targeting the relevant domains could block the interaction.
Host-directed antivirals: Compounds that modulate NPC1 function without completely disrupting its cellular role could provide a balance between antiviral efficacy and host toxicity.
Such approaches would likely have a high barrier to resistance since they target a host-virus interface rather than a viral component alone.
When studying E248R-host protein interactions, several controls are essential to ensure data reliability:
Negative interaction controls: Include an unrelated protein with similar characteristics (e.g., membrane association, similar size) to demonstrate specificity of observed interactions. For example, studies have used HA-eIF4E as a negative control to verify E248R-NPC1 interaction specificity .
Loading controls: Include cellular housekeeping proteins such as GAPDH, alpha-tubulin, or HSP90 to ensure equal loading across samples .
Expression controls: Include analysis of input samples (total cell lysates) to confirm expression of all proteins being studied before immunoprecipitation .
Antibody specificity controls: Validate antibody specificity through western blotting of known positive and negative samples.
Reciprocal co-immunoprecipitation: Confirm interactions by performing pull-downs in both directions to strengthen evidence for specific binding.
Implementation of these controls helps distinguish genuine protein-protein interactions from experimental artifacts and provides greater confidence in research findings.
The choice of cell type for studying E248R function depends on the specific research question:
HEK 293T cells: These cells have been extensively used for protein-protein interaction studies due to their high transfection efficiency and ease of culture . They are particularly useful for initial characterization of protein-protein interactions.
Macrophage cell lines: As natural host cells for ASFV, macrophage cell lines provide a more physiologically relevant context for studying E248R function in viral infection. Porcine macrophage lines are particularly relevant.
Vero cells: These cells have been used for studies involving recombinant ASFV with inducible E248R expression .
Porcine primary cells: For the most physiologically relevant context, primary porcine macrophages or other primary cells derived from the natural host provide valuable insights, though they may be more challenging to work with.
The optimal approach often involves confirming findings across multiple cell types, starting with more tractable systems like HEK 293T cells for initial characterization before moving to more physiologically relevant but technically challenging systems.
When faced with contradictory findings in E248R research, several approaches can help reconcile discrepancies:
Methodological variations analysis: Carefully compare experimental methods between studies, as differences in protein expression levels, cell types, detection methods, or buffer conditions can significantly impact results.
Replication with standardized protocols: Attempt to replicate contradictory findings using standardized protocols to determine if methodological differences explain the discrepancies.
Computational analysis tools: Employ advanced tools for clinical contradiction detection that can systematically identify and analyze conflicting statements in the literature .
Meta-analysis approaches: When multiple studies exist, formal meta-analysis can help identify patterns and reconcile apparently contradictory findings.
Combined methodological approaches: Use multiple complementary techniques to address the same question, as consistency across different methodological approaches strengthens confidence in results.
The field of contradiction detection in scientific literature has developed sophisticated approaches that can be applied to reconcile conflicting findings in E248R research .
Several promising research directions could significantly advance our understanding of E248R:
Structural biology approaches: High-resolution structural studies of E248R, particularly in complex with NPC1, would provide valuable insights for structure-based drug design.
Systems biology integration: Integrating E248R-host interaction data into broader virus-host interaction networks could reveal new functional connections and potential intervention points.
Comparative virology: Comparing E248R with functionally similar proteins in other viruses, such as the L1R protein in vaccinia virus which also interacts with NPC1 , could reveal evolutionary patterns and conserved mechanisms.
In vivo validation: Testing the importance of E248R-NPC1 interactions in animal models would validate the physiological relevance of findings from cell culture systems.
Immunological studies: Investigating the potential of E248R as a target for protective immune responses could inform vaccine development strategies.
These approaches, particularly when pursued in combination, hold promise for advancing both basic understanding of ASFV biology and applied aspects of antiviral development.
Structural biology approaches could provide transformative insights into E248R function:
Cryo-electron microscopy: This technique could reveal the structure of E248R in the context of the intact virion, providing insights into its spatial relationships with other viral proteins.
X-ray crystallography: Determination of the crystal structure of E248R, particularly in complex with NPC1 domains, would provide atomic-level details of the interaction interface.
NMR spectroscopy: For specific domains or fragments of E248R, NMR could provide information about dynamic properties and conformational changes.
Molecular dynamics simulations: Computational approaches based on structural data could predict how E248R interacts with membranes and how these interactions change during the fusion process.
Hydrogen-deuterium exchange mass spectrometry: This technique could identify regions of E248R that undergo conformational changes upon binding to NPC1 or other partners.
These structural insights would not only enhance our understanding of E248R function but could also guide the development of targeted interventions to disrupt its role in viral infection.